Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

8,823 evidence items · page 191 / 353

66.6 %Among 400 female students in tertiary institutions in Imo State, 265 (66.6%) have heard of cervical screening.

Nigeriacancer du col de l'utéruspublished 2021Journal of community healthPubMeddocument of 9 observations

4.6 %Dystonic cerebral palsy was present in 18 out of 388 children (4.6%).

Nigeriacerebral palsypublished 2020Archives of disease in childhoodPubMeddocument of 27 observations

99 %Among 352 breast cancer patients, 99% were female.

Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations

32 %Among the 200 study participants, 64 (32.0%) had a positive immediate family history of prostate cancer.

Nigeriacancer de la prostatepublished 2024American journal of men's healthPubMeddocument of 7 observations

49.4 %Triple-negative breast cancer (TNBC) accounted for 49.4% of cases.

Nigeriacancer du sein triple-négatifpublished 2024West African journal of medicinePubMeddocument of 13 observations

29.8 %The most commonly reported adverse drug reactions were neuropsychiatric disorders (29.8%).

Nigerianeuropsychiatric disorderspublished 2026BMC infectious diseasesPubMeddocument of 10 observations

54.4 %Females constituted 54.4% of the participants in both the type II diabetes mellitus and control groups.

Nigeriatype II diabetes mellituspublished 2023West African journal of medicinePubMeddocument of 8 observations

160,000 casesThe number of children newly infected with HIV was 160000 in 2021.

NigeriaVIH/sidaobserved 2021published 2023Journal of the International Association of Providers of AIDS CarePubMeddocument of 3 observations

5 %Gonorrhea testing increased from 5% at baseline to 43% at 6-month follow-up among youth participants.

Nigeriagonorrheapublished 2022AIDS patient care and STDsPubMeddocument of 7 observations

76,711 NGNThe median monthly economic burden for sickle cell disease patients was approximately N76,711 (US$385) per person.

Nigeriadrépanocytosepublished 2022PloS onePubMeddocument of 5 observations

62.9 yearsThe mean age of the 201 patients with type 2 diabetes was 62.9 ± 11.6 years.

Nigeriadiabète de type 2published 2021BMC health services researchPubMeddocument of 5 observations

1.27 %The overall yield of HIV in this intervention was 1.27%.

NigeriaVIH/sidaobserved 2017published 2022West African journal of medicinePubMeddocument of 14 observations

4 %The pooled prevalence of sickle cell disease among Nigerian children and adolescents was 4.0%.

Nigeriadrépanocytosepublished 2025Systematic reviewsPubMeddocument of 7 observations

27.9 %Overweight prevalence was 27.9% among people living with HIV on antiretroviral therapy in Nigeria.

Nigeriaoverweightobserved 2024published 2025AIDS research and therapyPubMeddocument of 7 observations

57.5 yearsThe mean age of the type 2 diabetes mellitus patients was 57.5 years.

Nigeriadiabète de type 2published 2024West African journal of medicinePubMeddocument of 10 observations

Malaria surveillance system in Kano State was simple, flexible, acceptable, useful and donor-driven but the data were not representative of all health facilities.

Nigeriapaludismepublished 2020Infectious diseases of povertyPubMeddocument of 3 observations

4.8 %Hepatitis C virus (HCV) prevalence was 4.8% among 248 patients at the Federal Medical Center, Makurdi.

Nigeriahépatite Cpublished 2024BMC public healthPubMeddocument of 7 observations

0.8 %The prevalence of SCD among the infant cohort was 0.8%.

Nigeriadrépanocytosepublished 2020PloS onePubMeddocument of 4 observations

0.42 rhoSerum magnesium correlated positively with fasting insulin (rho = 0.42, p = 0.003).

Nigeriadiabète de type 2PubMeddocument of 7 observations

22.3 %Malaria mortality coefficient of variation (COV) across Nigerian states declined to 22.3% in 2019.

Nigeriapaludismeobserved 2019published 2026Malaria journalPubMeddocument of 10 observations

17.6 %Among 17 HIV-infected, HIV-exposed infants in Plateau State, Nigeria who experienced treatment mortality or losses (TX_ML), 17.6% (3/17) discontinued treatment.

NigeriaVIH/sidaobserved 2018–2022published 2026PloS onePubMeddocument of 13 observations

5.3 odds_ratioHigh physical functioning score was a strong predictor of defaulters (OR = 5.3; 95%CI: 2.11–9.05, p = 0.01).

Nigeriatuberculosepublished 2018Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 6 observations

26.7 %The prevalence of alcohol intake was 26.7% among the screened participants in Lagos, Nigeria.

Nigeriaalcohol intakeobserved 2018published 2020International journal of clinical pharmacyPubMeddocument of 10 observations

-0.108 beta_coefficientFunctional social support had a significant diminishing effect on HIV-related stigma in Miami (β = -0.108) and Port Harcourt (β = -0.035).

NigeriaVIH/sidapublished 2020Journal of racial and ethnic health disparitiesPubMeddocument of 5 observations

35 yearsA germline TP53 pathogenic variant, TP53 c.694dupA (p.Ile232Asnfs), was identified in a 35-year-old triple-negative breast cancer patient with recurrent metastatic disease.

Nigeriacancer du sein triple-négatifpublished 2026Cancer geneticsPubMeddocument of 4 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.